301239 普瑞眼科
已收盘 04-27 15:00:00
资讯
新帖
简况
图解普瑞眼科年报：第四季度单季净利润同比增长34.35%
证券之星 · 01:58
图解普瑞眼科年报：第四季度单季净利润同比增长34.35%
4月24日普瑞眼科涨8.62%，融通健康产业灵活配置混合A/B基金重仓该股
证券之星 · 04-24
4月24日普瑞眼科涨8.62%，融通健康产业灵活配置混合A/B基金重仓该股
普瑞眼科（301239）披露使用部分超募资金永久补充流动资金公告，4月7日股价上涨3.5%
证券之星 · 04-07
普瑞眼科（301239）披露使用部分超募资金永久补充流动资金公告，4月7日股价上涨3.5%
普瑞眼科（301239）披露归还暂时补充流动资金的闲置募集资金公告，4月3日股价上涨1.5%
证券之星 · 04-03
普瑞眼科（301239）披露归还暂时补充流动资金的闲置募集资金公告，4月3日股价上涨1.5%
3月30日普瑞眼科涨8.07%，融通健康产业灵活配置混合A/B基金重仓该股
证券之星 · 03-30
3月30日普瑞眼科涨8.07%，融通健康产业灵活配置混合A/B基金重仓该股
普瑞眼科（301239）披露变更持续督导保荐代表人公告，3月27日股价上涨1.63%
证券之星 · 03-27
普瑞眼科（301239）披露变更持续督导保荐代表人公告，3月27日股价上涨1.63%
普瑞眼科（301239）披露控股股东部分股份解除质押公告，3月23日股价下跌7.06%
证券之星 · 03-23
普瑞眼科（301239）披露控股股东部分股份解除质押公告，3月23日股价下跌7.06%
普瑞眼科（301239）披露控股股东部分股份解除质押公告，3月20日股价下跌1.43%
证券之星 · 03-20
普瑞眼科（301239）披露控股股东部分股份解除质押公告，3月20日股价下跌1.43%
普瑞眼科（301239）披露控股股东部分股份质押及解除质押公告，3月10日股价上涨4.57%
中金财经 · 03-11
普瑞眼科（301239）披露控股股东部分股份质押及解除质押公告，3月10日股价上涨4.57%
普瑞眼科（301239）股东成都普瑞世纪投资有限责任公司质押1246.4万股，占总股本8.33%
证券之星 · 03-10
普瑞眼科（301239）股东成都普瑞世纪投资有限责任公司质押1246.4万股，占总股本8.33%
3月9日普瑞眼科涨5.28%，融通健康产业灵活配置混合A/B基金重仓该股
证券之星 · 03-09
3月9日普瑞眼科涨5.28%，融通健康产业灵活配置混合A/B基金重仓该股
普瑞眼科（301239）股东成都普瑞世纪投资有限责任公司质押395万股，占总股本2.64%
证券之星 · 03-02
普瑞眼科（301239）股东成都普瑞世纪投资有限责任公司质押395万股，占总股本2.64%
股市必读：普瑞眼科（301239）预计2025年全年营业收入27.5亿元至28.5亿元
证券之星 · 02-02
股市必读：普瑞眼科（301239）预计2025年全年营业收入27.5亿元至28.5亿元
普瑞眼科（301239）披露2025年度业绩预告，1月30日股价下跌2.7%
证券之星 · 01-30
普瑞眼科（301239）披露2025年度业绩预告，1月30日股价下跌2.7%
股市必读：普瑞眼科（301239）1月20日董秘有最新回复
证券之星 · 01-21
股市必读：普瑞眼科（301239）1月20日董秘有最新回复
普瑞眼科：新医院尚未整体进入业绩释放期
证券之星 · 01-20
普瑞眼科：新医院尚未整体进入业绩释放期
股市必读：普瑞眼科（301239）1月16日董秘有最新回复
证券之星 · 01-19
股市必读：普瑞眼科（301239）1月16日董秘有最新回复
普瑞眼科：公司若触发业绩预告披露情形将依规披露
证券之星 · 01-16
普瑞眼科：公司若触发业绩预告披露情形将依规披露
普瑞眼科（301239）披露注销部分募集资金专项账户，1月14日股价上涨0.59%
证券之星 · 01-14
普瑞眼科（301239）披露注销部分募集资金专项账户，1月14日股价上涨0.59%
每周股票复盘：普瑞眼科（301239）开展2025年度持续督导培训
证券之星 · 01-03
每周股票复盘：普瑞眼科（301239）开展2025年度持续督导培训
加载更多
公司概况
公司名称：
普瑞眼科医院集团股份有限公司
所属行业：
卫生
上市日期：
2022-07-05
主营业务：
普瑞眼科医院集团股份有限公司的主营业务是各类眼科疾病诊疗服务与医学验光配镜。公司的主要产品是屈光项目、白内障项目、视光项目、综合眼病项目。2025年4月，公司正式披露《2024年度环境、社会及公司治理报告》，这是公司连续第三年发布ESG报告，披露后公司WindESG评级提升至A级，在A股医疗服务行业中位居前列。
发行价格：
33.65
{"stockData":{"symbol":"301239","market":"SZ","secType":"STK","nameCN":"普瑞眼科","latestPrice":42,"timestamp":1777273395000,"preClose":42.84,"halted":0,"volume":3212190,"delay":0,"changeRate":-0.0196,"floatShares":150000000,"shares":150000000,"eps":-0.6775,"marketStatus":"已收盘","change":-0.84,"latestTime":"04-27 15:00:00","open":42.42,"high":43.29,"low":41.7,"amount":136000000,"amplitude":0.0371,"askPrice":42,"askSize":34,"bidPrice":41.99,"bidSize":80,"shortable":0,"etf":0,"ttmEps":-0.6775,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777339800000},"marketStatusCode":5,"adr":0,"adjPreClose":42.84,"symbolType":"stock","openAndCloseTimeList":[[1777253400000,1777260600000],[1777266000000,1777273200000]],"highLimit":47.12,"lowLimit":38.56,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":149619048,"isCdr":false,"pbRate":3.02,"roa":"--","roe":"0.77%","epsLYR":-0.68,"committee":0.350877,"marketValue":6284000000,"turnoverRate":0.0215,"status":1,"floatMarketCap":6284000000},"requestUrl":"/m/hq/s/301239","defaultTab":"news","newsList":[{"id":"2630115553","title":"图解普瑞眼科年报：第四季度单季净利润同比增长34.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630115553","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630115553?lang=zh_cn&edition=full","pubTime":"2026-04-28 01:58","pubTimestamp":1777312738,"startTime":"0","endTime":"0","summary":"证券之星消息，普瑞眼科2025年年报显示，当年度公司主营收入27.97亿元，同比上升4.44%；归母净利润-6092.26万元，同比上升40.19%；扣非净利润-4820.61万元，同比上升43.43%；其中2025年第四季度，公司单季度主营收入5.97亿元，同比上升10.18%；单季度归母净利润-7727.18万元，同比上升34.35%；单季度扣非净利润-7287.59万元，同比上升29.61%；负债率54.63%，投资收益-1089.29万元，财务费用8824.39万元，毛利率35.91%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800005425.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629681608","title":"4月24日普瑞眼科涨8.62%，融通健康产业灵活配置混合A/B基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629681608","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629681608?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:37","pubTimestamp":1777019873,"startTime":"0","endTime":"0","summary":"证券之星消息，4月24日普瑞眼科涨8.62%创60日新高，收盘报42.84元，换手率6.08%，成交量9.09万手，成交额3.89亿元。重仓普瑞眼科的前十大公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共11家，其中持有数量最多的公募基金为融通基金的融通健康产业灵活配置混合A/B。融通健康产业灵活配置混合A/B目前规模为14.07亿元，最新净值2.661，较上一交易日下跌0.26%，近一年上涨13.14%。该公募基金现任基金经理为万民远。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400050540.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301239","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625595947","title":"普瑞眼科（301239）披露使用部分超募资金永久补充流动资金公告，4月7日股价上涨3.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625595947","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625595947?lang=zh_cn&edition=full","pubTime":"2026-04-07 22:28","pubTimestamp":1775572096,"startTime":"0","endTime":"0","summary":"近日，普瑞眼科医院集团股份有限公司披露《关于使用部分超募资金永久补充流动资金的公告》。公告显示，公司于2026年4月7日召开第四届董事会第二次会议，审议通过使用部分超募资金永久补充流动资金的议案，拟使用超募资金24,000.00万元人民币用于永久补充流动资金，占超募资金总额的29.53%，该事项尚需提交公司股东会审议。公司超募资金总额为812,724,292.69元，已累计使用57,549.93万元，剩余23,722.50万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700033591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624635586","title":"普瑞眼科（301239）披露归还暂时补充流动资金的闲置募集资金公告，4月3日股价上涨1.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624635586","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624635586?lang=zh_cn&edition=full","pubTime":"2026-04-03 22:33","pubTimestamp":1775226794,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，普瑞眼科报收于36.54元，较前一交易日上涨1.5%，最新总市值为54.67亿元。近日，普瑞眼科医院集团股份有限公司发布《关于归还暂时补充流动资金的闲置募集资金的公告》。公告显示，公司于2025年4月7日召开第三届董事会第三十次会议，审议通过使用不超过25,000万元闲置募集资金暂时补充流动资金，使用期限不超过12个月。截至2026年4月2日，公司已将25,000万元全部归还至募集资金专用账户，并通知保荐机构和保荐代表人。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300043709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301239","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623970173","title":"3月30日普瑞眼科涨8.07%，融通健康产业灵活配置混合A/B基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2623970173","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623970173?lang=zh_cn&edition=full","pubTime":"2026-03-30 16:29","pubTimestamp":1774859384,"startTime":"0","endTime":"0","summary":"证券之星消息，3月30日普瑞眼科涨8.07%，收盘报36.43元，换手率3.11%，成交量4.65万手，成交额1.67亿元。重仓普瑞眼科的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共9家，其中持有数量最多的公募基金为融通基金的融通健康产业灵活配置混合A/B。融通健康产业灵活配置混合A/B目前规模为14.79亿元，最新净值2.622，较上一交易日上涨2.3%，近一年上涨7.5%。该公募基金现任基金经理为万民远。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000021621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622878018","title":"普瑞眼科（301239）披露变更持续督导保荐代表人公告，3月27日股价上涨1.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622878018","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622878018?lang=zh_cn&edition=full","pubTime":"2026-03-27 22:36","pubTimestamp":1774622179,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，普瑞眼科报收于33.71元，较前一交易日上涨1.63%，最新总市值为50.44亿元。普瑞眼科医院集团股份有限公司于2026年3月27日发布公告，因原持续督导保荐代表人田卓玲女士工作安排变动，国泰海通证券委派叶盛荫先生接替其职务，继续履行公司首次公开发行股票并在创业板上市后的持续督导职责。持续督导期至中国证监会和深交所规定结束为止。本次变更不影响公司正常经营。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700050386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621707850","title":"普瑞眼科（301239）披露控股股东部分股份解除质押公告，3月23日股价下跌7.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621707850","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621707850?lang=zh_cn&edition=full","pubTime":"2026-03-23 22:50","pubTimestamp":1774277428,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，普瑞眼科报收于32.0元，较前一交易日下跌7.06%，最新总市值为47.88亿元。普瑞眼科医院集团股份有限公司于近日披露《关于控股股东部分股份解除质押的公告》。公告显示，公司接到控股股东成都普瑞世纪投资有限责任公司通知，普瑞投资将其持有的6,211,200股公司股份办理了解除质押手续，占其所持股份比例11.56%，占公司总股本比例4.15%，质权人为西藏信托有限公司。本次解除质押后，普瑞投资累计质押股份为29,804,000股，占其所持股份比例55.47%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300040279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620673209","title":"普瑞眼科（301239）披露控股股东部分股份解除质押公告，3月20日股价下跌1.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620673209","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620673209?lang=zh_cn&edition=full","pubTime":"2026-03-20 22:42","pubTimestamp":1774017738,"startTime":"0","endTime":"0","summary":"公司于近日披露《关于控股股东部分股份解除质押的公告》。公告显示，普瑞眼科医院集团股份有限公司接到控股股东成都普瑞世纪投资有限责任公司通知，普瑞投资将其持有的公司3,300,000股股份办理了解除质押手续，占其所持股份比例6.14%，占公司总股本比例2.21%，质押起始日为2023年3月17日，解除日为2026年3月19日，质权人为成都中小企业融资担保有限责任公司。本次解除质押后，普瑞投资累计质押股份为36,015,200股，占其持股比例67.03%，占公司总股本24.07%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000043945.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618998328","title":"普瑞眼科（301239）披露控股股东部分股份质押及解除质押公告，3月10日股价上涨4.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618998328","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618998328?lang=zh_cn&edition=full","pubTime":"2026-03-11 08:04","pubTimestamp":1773187478,"startTime":"0","endTime":"0","summary":"普瑞眼科医院集团股份有限公司于2026年3月10日发布《关于控股股东部分股份质押及解除质押的公告》。公告显示，控股股东成都普瑞世纪投资有限责任公司本次合计质押12,464,000股，占公司总股本8.33%，质押用途为融资；同时合计解除质押3,880,000股，占公司总股本2.59%。本次变动后，普瑞投资累计质押股份占其所持股份比例为73.17%，占公司总股本26.28%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260311/32059009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["301239","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618939088","title":"普瑞眼科（301239）股东成都普瑞世纪投资有限责任公司质押1246.4万股，占总股本8.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618939088","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618939088?lang=zh_cn&edition=full","pubTime":"2026-03-10 18:24","pubTimestamp":1773138275,"startTime":"0","endTime":"0","summary":"证券之星消息，普瑞眼科3月10日公开信息显示，股东成都普瑞世纪投资有限责任公司向成都中小企业融资担保有限责任公司、云南国际信托有限公司合计质押1246.4万股，占总股本8.33%。质押详情见下表：截止本公告日，股东成都普瑞世纪投资有限责任公司已累计质押股份3931.52万股，占其持股总数的73.17%。普瑞眼科主营业务：致力于为眼科疾病患者提供诊断、治疗、保健及医学验光配镜等眼科全科医疗服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000030977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618646627","title":"3月9日普瑞眼科涨5.28%，融通健康产业灵活配置混合A/B基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2618646627","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618646627?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:26","pubTimestamp":1773044780,"startTime":"0","endTime":"0","summary":"证券之星消息，3月9日普瑞眼科涨5.28%，收盘报33.9元，换手率2.66%，成交量3.98万手，成交额1.34亿元。重仓普瑞眼科的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共9家，其中持有数量最多的公募基金为融通基金的融通健康产业灵活配置混合A/B。融通健康产业灵活配置混合A/B目前规模为14.79亿元，最新净值2.716，较上一交易日上涨1.72%，近一年上涨11.72%。该公募基金现任基金经理为万民远。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030900021050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301239","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616333961","title":"普瑞眼科（301239）股东成都普瑞世纪投资有限责任公司质押395万股，占总股本2.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616333961","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616333961?lang=zh_cn&edition=full","pubTime":"2026-03-02 18:34","pubTimestamp":1772447694,"startTime":"0","endTime":"0","summary":"证券之星消息，普瑞眼科3月2日公开信息显示，股东成都普瑞世纪投资有限责任公司向中原信托有限公司合计质押395.0万股，占总股本2.64%。质押详情见下表：截止本公告日，股东成都普瑞世纪投资有限责任公司已累计质押股份3073.12万股，占其持股总数的57.2%。普瑞眼科主营业务：致力于为眼科疾病患者提供诊断、治疗、保健及医学验光配镜等眼科全科医疗服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200030276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301239","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608881633","title":"股市必读：普瑞眼科（301239）预计2025年全年营业收入27.5亿元至28.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608881633","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608881633?lang=zh_cn&edition=full","pubTime":"2026-02-02 04:28","pubTimestamp":1769977689,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，普瑞眼科报收于34.65元，下跌2.7%，换手率1.12%，成交量1.67万手，成交额5845.12万元。业绩披露要点业绩预告普瑞眼科发布业绩预告，预计2025年全年扣非后净利润亏损3700万元至5200万元；预计2025年全年营业收入27.5亿元至28.5亿元；预计2025年全年归属净利润亏损5000万元至6900万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200002088.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607042608","title":"普瑞眼科（301239）披露2025年度业绩预告，1月30日股价下跌2.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607042608","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607042608?lang=zh_cn&edition=full","pubTime":"2026-01-30 23:23","pubTimestamp":1769786593,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，普瑞眼科报收于34.65元，较前一交易日下跌2.7%，最新总市值为51.84亿元。该股当日开盘35.35元，最高35.85元，最低34.35元，成交额达5845.12万元，换手率为1.12%。普瑞眼科于近日披露《2025年度业绩预告》。公告显示，公司预计2025年度归属于上市公司股东的净利润为-6,900万元至-5,000万元，扣除非经常性损益后的净利润为-5,200万元至-3,700万元，较上年同期亏损收窄；营业收入预计为27.5亿元至28.5亿元，同比增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000048327.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605414374","title":"股市必读：普瑞眼科（301239）1月20日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2605414374","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605414374?lang=zh_cn&edition=full","pubTime":"2026-01-21 02:43","pubTimestamp":1768934588,"startTime":"0","endTime":"0","summary":"截至2026年1月20日收盘，普瑞眼科报收于33.67元，下跌0.59%，换手率0.81%，成交量1.21万手，成交额4079.55万元。董秘最新回复投资者： 董秘您好，非常支持并理解公司的扩张经营进取策略，做为持有者非常想了解近年新开医院的近况。根据公司公开信息，2023-2025年间新增了12家医院。公司在新建医院前均经过审慎评估与规划。当日关注点来自交易信息汇总：1月20日主力资金净流出585.54万元，显示主力短期谨慎态度。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100001155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604162946","title":"普瑞眼科：新医院尚未整体进入业绩释放期","url":"https://stock-news.laohu8.com/highlight/detail?id=2604162946","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604162946?lang=zh_cn&edition=full","pubTime":"2026-01-20 15:04","pubTimestamp":1768892658,"startTime":"0","endTime":"0","summary":"请问从管理角度看，这些新院25年是否已整体进入业绩释放期？公司近年新开设的医院目前仍处于市场培育和收入爬坡阶段，尚未整体进入业绩释放期，这一发展节奏符合民营医院行业的普遍规律，也与公司的预期基本一致。为科学评估新医院的经营进展，公司已建立一套多维度的运营考核体系，我们重点关注门诊量、手术量、营业收入等成长性指标，同时也会动态监测业务结构优化与净利润改善等情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000017996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301239","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604972548","title":"股市必读：普瑞眼科（301239）1月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2604972548","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604972548?lang=zh_cn&edition=full","pubTime":"2026-01-19 04:12","pubTimestamp":1768767130,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，普瑞眼科报收于33.85元，下跌1.37%，换手率0.99%，成交量1.48万手，成交额5020.58万元。公司股价受市场多重因素影响，我们实时关注股价波动并始终重视投资者的回报。公司若触发业绩预告披露情形，将在会计年度结束后1个月内依规披露；未触发则无需披露。当日关注点来自交易信息汇总：1月16日主力资金净流出106.58万元，显示主力小幅减持动向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900001568.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301239","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603956412","title":"普瑞眼科：公司若触发业绩预告披露情形将依规披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2603956412","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603956412?lang=zh_cn&edition=full","pubTime":"2026-01-16 11:36","pubTimestamp":1768534578,"startTime":"0","endTime":"0","summary":"证券之星消息，普瑞眼科01月16日在投资者关系平台上答复投资者关心的问题。公司股价受市场多重因素影响，我们实时关注股价波动并始终重视投资者的回报。公司若触发业绩预告披露情形，将在会计年度结束后1个月内依规披露；未触发则无需披露。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600015387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301239","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603612993","title":"普瑞眼科（301239）披露注销部分募集资金专项账户，1月14日股价上涨0.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603612993","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603612993?lang=zh_cn&edition=full","pubTime":"2026-01-14 22:37","pubTimestamp":1768401430,"startTime":"0","endTime":"0","summary":"截至2026年1月14日收盘，普瑞眼科报收于34.26元，较前一交易日上涨0.59%，最新总市值为51.26亿元。该股当日开盘33.99元，最高35.1元，最低33.61元，成交额达1.02亿元，换手率为1.98%。截至公告日，上述账户注销手续已完成，对应的监管协议终止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400041550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600928067","title":"每周股票复盘：普瑞眼科（301239）开展2025年度持续督导培训","url":"https://stock-news.laohu8.com/highlight/detail?id=2600928067","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600928067?lang=zh_cn&edition=full","pubTime":"2026-01-03 02:50","pubTimestamp":1767379817,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，普瑞眼科报收于32.89元，较上周的31.22元上涨5.35%。本周，普瑞眼科12月31日盘中最高价报34.1元。12月30日盘中最低价报30.75元。普瑞眼科当前最新总市值49.21亿元，在医疗服务板块市值排名34/51，在两市A股市值排名3399/5181。公司公告汇总国泰海通证券股份有限公司作为普瑞眼科医院集团股份有限公司的保荐机构，于2025年12月22日以现场与线上相结合的方式开展了2025年度持续督导培训。公司对本次培训积极配合，达到了预期效果。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300000703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301239","BK0236"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777329724107,"stockEarnings":[{"period":"1week","weight":0.0842},{"period":"1month","weight":0.2459},{"period":"3month","weight":0.1939},{"period":"6month","weight":0.1239},{"period":"1year","weight":0.0174},{"period":"ytd","weight":0.277}],"compareEarnings":[{"period":"1week","weight":0.001},{"period":"1month","weight":0.0441},{"period":"3month","weight":-0.0129},{"period":"6month","weight":0.0174},{"period":"1year","weight":0.2401},{"period":"ytd","weight":0.0296}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"普瑞眼科医院集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"9923人(较上一季度减少9.82%)","perCapita":"14314股","listingDate":"2022-07-05","address":"四川省成都市金牛区一环路北四段215号","registeredCapital":"14961万元","survey":" 普瑞眼科医院集团股份有限公司的主营业务是各类眼科疾病诊疗服务与医学验光配镜。公司的主要产品是屈光项目、白内障项目、视光项目、综合眼病项目。2025年4月，公司正式披露《2024年度环境、社会及公司治理报告》，这是公司连续第三年发布ESG报告，披露后公司WindESG评级提升至A级，在A股医疗服务行业中位居前列。","listedPrice":33.65},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"普瑞眼科(301239)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供普瑞眼科(301239)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"普瑞眼科,301239,普瑞眼科股票,普瑞眼科股票老虎,普瑞眼科股票老虎国际,普瑞眼科行情,普瑞眼科股票行情,普瑞眼科股价,普瑞眼科股市,普瑞眼科股票价格,普瑞眼科股票交易,普瑞眼科股票购买,普瑞眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"普瑞眼科(301239)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供普瑞眼科(301239)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}